The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier
Open accessAbstract
Facilitated pyruvate transport across the mitochondrial inner membrane is a critical step in carbohydrate, amino acid, and lipid metabolism. We report that clinically relevant concentrations of thiazolidinediones (TZDs), a widely used class of insulin sensitizers, acutely and specifically inhibit mitochondrial pyruvate carrier (MPC) activity in a variety of cell types. Respiratory inhibition was overcome with methyl pyruvate, localizing the effect to facilitated pyruvate transport, and knockdown of either paralog, MPC1 or MPC2, decreased the EC 50 for respiratory inhibition by TZDs. Acute MPC inhibition significantly enhanced glucose uptake in human skeletal muscle myocytes after 2 h. These data ( i ) report that clinically used TZDs inhibit the MPC, ( ii ) validate that MPC1 and MPC2 are obligatory components of facilitated pyruvate transport in mammalian cells, ( iii ) indicate that the acute effect of TZDs may be related to insulin sensitization, and ( iv ) establish mitochondrial pyruvate uptake as a potential therapeutic target for diseases rooted in metabolic dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since MSDC-0602 K retains a weak PPARγ binding affinity, the observed improvement in insulin sensitivity may not be solely mediated via MPC modulation [187].”
From Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease? (2024) · cites this paper as [187]
Experimental — accuracy not yet measuredIn the citing paper
“This shift is evident in cancer cells, which repress MPC1 to promote the Warburg Effect, and in myocytes of diabetic mice, which elevate glucose consumption in response to MPC inhibition22,23”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [23]
In the citing paper
“In fact, the MPC has emerged as an unanticipated target of thiazolidinediones (Colca et al., 2013; Divakaruni et al., 2013), a class of insulin sensitizing drugs, and as a regulator of insulin secretion (Patterson et al., 2014; Vigueira et al., 2014);”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Divakaruni et al., 2013
In the citing paper
“Knockdown of either Mpc1 or Mpc2 abrogated expression of both proteins, as observed previously (Divakaruni et al., 2013).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Divakaruni et al., 2013
In the citing paper
“Our analyses also more explicitly delineate the roles of MPC1 and MPC2 as components of the mitochondrial pyruvate transporter.”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Divakaruni et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,645
Fryer, L. G. D., Patel, A. P., & Carling, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202489200 · Cited by 1,035
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Choi, J. H., Banks, A. S., Estall, J. L., Kajimura, S., Boström, P., Laznik, D., Ruas, J. L., Chalmers, M. J., Kamenecka, T. M., Blüher, M., et al. (2010) · Nature · doi:10.1038/nature09291 · Cited by 897
A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila , and Humans
Bricker, D. K., Taylor, E. B., Schell, J. C., Orsak, T., Boutron, A., Chen, Y.-C., Cox, J. E., Cardon, C. M., Van Vranken, J. G., Dephoure, N., et al. (2012) · Science · doi:10.1126/science.1218099 · Cited by 843
Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
Hawley, S. A., Ross, F. A., Chevtzoff, C., Green, K. A., Evans, A., Fogarty, S., Towler, M. C., Brown, L. J., Ogunbayo, O. A., Evans, A. M., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.001 · Cited by 773
Identification and Functional Expression of the Mitochondrial Pyruvate Carrier
Herzig, S., Raemy, E., Montessuit, S., Veuthey, J.-L., Zamboni, N., Westermann, B., Kunji, E. R. S., & Martinou, J.-C. (2012) · Science · doi:10.1126/science.1218530 · Cited by 747
Brain fuel metabolism, aging, and Alzheimer’s disease
Cunnane, S. C., Nugent, S., Roy, M., Courchesne‐Loyer, A., Croteau, É., Tremblay, S., Castellano, A., Pifferi, F., Bocti, C., Paquet, N., et al. (2010) · Nutrition · doi:10.1016/j.nut.2010.07.021 · Cited by 633
The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors
Halestrap, A. P. (1975) · Biochemical Journal · doi:10.1042/bj1480085 · Cited by 543
Thiazolidinediones, Like Metformin, Inhibit Respiratory Complex I
Brunmair, B., Staniek, K., Gras, F., Scharf, N., Althaym, A., Clara, R., Roden, M., Gnaiger, E., Nohl, H., Waldhäusl, W., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1052 · Cited by 521
Graham, D. J., Ouellet‐Hellstrom, R., MaCurdy, T. E., Ali, F. N., Sholley, C., Worrall, C. M., & Kelman, J. A. (2010) · JAMA · doi:10.1001/jama.2010.920 · Cited by 512
Cited by
Sorted by citations
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
The multifaceted contributions of mitochondria to cellular metabolism
Spinelli, J. B., & Haigis, M. C. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0124-1 · Cited by 1,935
Regulation of pyruvate metabolism and human disease
Gray, L. R., Tompkins, S. C., & Taylor, E. B. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1539-2 · Cited by 990
PPARs in Obesity-Induced T2DM, Dyslipidaemia and NAFLD
Gross, B., Pawlak, M., Lefebvre, P., & Staels, B. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.135 · Cited by 778
Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
Samuel, V. T., & Shulman, G. I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.002 · Cited by 745
“These proteins were discovered to be inhibited by TZD compounds and putatively mediate some of the insulin-sensitizing effects of these drugs; decreased mitochondrial pyruvate oxidation may promote AMPK-mediated muscle glucose uptake (Divakaruni et al., 2013).”
Yang, C., Ko, B., Hensley, C. T., Jiang, L., Wasti, A. T., Kim, J., Sudderth, J., Calvaruso, M. A., Lumata, L., Mitsche, M., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.025 · Cited by 679
Heart Failure in Type 2 Diabetes Mellitus
Kenny, H., & Abel, E. D. (2019) · Circulation Research · doi:10.1161/circresaha.118.311371 · Cited by 682
Analysis and Interpretation of Microplate-Based Oxygen Consumption and pH Data
Divakaruni, A. S., Paradyse, A. R., Ferrick, D. A., Murphy, A. N., & Jastroch, M. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801415-8.00016-3 · Cited by 543
Self-citationThe Browning of White Adipose Tissue: Some Burning Issues
Nedergaard, J., & Cannon, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.005 · Cited by 509
Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes
Soccio, R. E., Chen, E. R., & Lazar, M. A. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.005 · Cited by 518
Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis
Green, C. R., Wallace, M., Divakaruni, A. S., Phillips, S. A., Murphy, A. N., Ciaraldi, T. P., & Metallo, C. M. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.1961 · Cited by 471
Self-citationEnergy Metabolism of the Osteoblast: Implications for Osteoporosis
Lee, W.-C., Guntur, A. R., Long, F., & Rosen, C. J. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00064 · Cited by 443
Acetate Production from Glucose and Coupling to Mitochondrial Metabolism in Mammals
Liu, X., Cooper, D. E., Cluntun, A. A., Warmoes, M. O., Zhao, S., Reid, M. A., Liu, J., Lund, P. J., Lopes, M. D. C., Garcia, B. A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.040 · Cited by 421
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
Rines, A. K., Sharabi, K., Tavares, C. D. J., & Puigserver, P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.151 · Cited by 390
Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis
Divakaruni, A. S., Hsieh, W. Y., Minarrieta, L., Duong, T., Kim, K. K. O., Desousa, B. R., Andreyev, A. Y., Bowman, C. E., Caradonna, K. L., Dranka, B. P., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.001 · Cited by 364
Self-citationSchell, J. C., Olson, K. A., Jiang, L., Hawkins, A. J., Van Vranken, J. G., Xie, J., Egnatchik, R. A., Earl, E. G., DeBerardinis, R. J., & Rutter, J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.026 · Cited by 363
Photoaffinity Labeling in Target- and Binding-Site Identification
Smith, E. M., & Collins, I. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.14.152 · Cited by 371
The emerging role of mass spectrometry-based proteomics in drug discovery
Meissner, F., Geddes‐McAlister, J., Mann, M., & Bantscheff, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00409-3 · Cited by 373
Salabei, J. K., Gibb, A., & Hill, B. G. (2014) · Nature Protocols · doi:10.1038/nprot.2014.018 · Cited by 333
Sunny, N. E., Bril, F., & Cusi, K. J. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.11.006 · Cited by 327
Critical Role of Glucose Metabolism in Rheumatoid Arthritis Fibroblast‐like Synoviocytes
Garcia‐Carbonell, R., Divakaruni, A. S., Lodi, A., Vicente-Suarez, I., Saha, A., Cheroutre, H., Boss, G. R., Tiziani, S., Murphy, A. N., & Gumá, M. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39608 · Cited by 322
Self-citationLactate supports a metabolic-epigenetic link in macrophage polarization
Noe, J. T., Rendon, B. E., Geller, A. E., Conroy, L. R., Morrissey, S. M., Young, L. E. A., Bruntz, R. C., Kim, E. J., Wise, A. D., Rizzo, M. B. D. S., et al. (2021) · Science Advances · doi:10.1126/sciadv.abi8602 · Cited by 295
Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier
Vacanti, N. M., Divakaruni, A. S., Green, C. R., Parker, S. J., Henry, R. R., Ciaraldi, T. P., Murphy, A. N., & Metallo, C. M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.024 · Cited by 277
Self-citationMitochondrial pyruvate transport: a historical perspective and future research directions
McCommis, K. S., & Finck, B. N. (2015) · Biochemical Journal · doi:10.1042/bj20141171 · Cited by 277
Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane
Kenwood, B. M., Weaver, J. L., Bajwa, A., Poon, I. K., Byrne, F. L., Murrow, B. A., Calderone, J. A., Huang, L., Divakaruni, A. S., Tomsig, J. L., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.005 · Cited by 243
Self-citationGray, L. R., Sultana, M. R., Rauckhorst, A. J., Oonthonpan, L., Tompkins, S. C., Sharma, A., Fu, X., Miao, R., Pewa, A. D., Brown, K., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.027 · Cited by 218
McCommis, K. S., Chen, Z., Fu, X., McDonald, W. G., Colca, J. R., Kletzien, R. F., Burgess, S. C., & Finck, B. N. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.028 · Cited by 211
Self-citationCheng, G., Zielonka, J., Ouari, O., López, M., McAllister, D. M., Boyle, K., Barrios, C. S., Weber, J. J., Johnson, B. D., Hardy, M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2534 · Cited by 216
Harrison, S. A., Alkhouri, N., Davison, B. A., Sanyal, A., Edwards, C., Colca, J. R., Lee, B. H., Loomba, R., Cusi, K., Kolterman, O., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.023 · Cited by 211
Self-citationImaging Mitochondrial Flux in Single Cells with a FRET Sensor for Pyruvate
San Martín, A., Ceballo, S., Baeza-Lehnert, F., Lerchundi, R., Valdebenito, R., Contreras-Baeza, Y., Alegría, K., & Barros, L. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085780 · Cited by 197
Corbet, C., Bastien, E., Draoui, N., Doix, B., Mignion, L., Jordan, B. F., Marchand, A., Vanherck, J., Chaltin, P., Schakman, O., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03525-0 · Cited by 189
Ghosh, A., Tyson, T., George, S., Hildebrandt, E. N., Steiner, J. A., Madaj, Z., Schulz, E., Machiela, E., McDonald, W. G., Galvis, M. L. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag2210 · Cited by 193
Self-citationHallmarks of a new era in mitochondrial biochemistryPreprint
Pagliarini, D. J., & Rutter, J. P. (2013) · Genes & Development · doi:10.1101/gad.229724.113 · Cited by 184
Yin, Y., Choi, S., Xu, Z., Zeumer, L., Kanda, N., Croker, B. P., & Morel, L. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501537 · Cited by 171
The multifaceted pyruvate metabolism: role of the mitochondrial pyruvate carrier
Zangari, J., Petrelli, F., Maillot, B., & Martinou, J.-C. (2020) · Biomolecules · doi:10.3390/biom10071068 · Cited by 172
Colca, J. R., McDonald, W. G., Cavey, G. S., Cole, S. L., Holewa, D. D., Brightwell-Conrad, A. S., Wolfe, C. L., Wheeler, J. S., Coulter, K. R., Kilkuskie, P. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061551 · Cited by 171
Self-citationSalabei, J. K., & Hill, B. G. (2013) · Redox Biology · doi:10.1016/j.redox.2013.10.011 · Cited by 169
Bader, D. A., Hartig, S. M., Putluri, V., Foley, C., Hamilton, M. P., Smith, E. A., Saha, P., Panigrahi, A., Walker, C. M., Zong, L., et al. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0002-y · Cited by 168
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
Huttasch, M., Roden, M., & Kahl, S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155937 · Cited by 169
Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death
Divakaruni, A. S., Wallace, M., Buren, C., Martyniuk, K. M., Andreyev, A. Y., Li, E., Fields, J. A., Cordes, T., Reynolds, I. J., Bloodgood, B. L., et al. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201612067 · Cited by 169
Self-citationInsulin Resistance and Mitochondrial Dysfunction
González-Franquesa, A., & Patti, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_25 · Cited by 160
Divakaruni, A. S., & Jastroch, M. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00619-4 · Cited by 162
Self-citationPPARγ is a nexus controlling alternative activation of macrophages via glutamine metabolismPreprint
Nelson, V. L., Nguyen, H. C. B., García‐Cañaveras, J. C., Briggs, E. R., Ho, W. Y., DiSpirito, J. R., Marinis, J. M., Hill, D. A., & Lazar, M. A. (2018) · Genes & Development · doi:10.1101/gad.312355.118 · Cited by 147
Divakaruni, A. S., Rogers, G. W., & Murphy, A. N. (2014) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx2502s60 · Cited by 141
Self-citationMcCommis, K. S., Hodges, W. T., Brunt, E. M., Nalbantoglu, I., McDonald, W. G., Holley, C. L., Fujiwara, H., Schaffer, J. E., Colca, J. R., & Finck, B. N. (2016) · Hepatology · doi:10.1002/hep.29025 · Cited by 139
Self-citationRaho, S., Capobianco, L., Malivindi, R., Vozza, A., Piazzolla, C., Leonardis, F. D., Gorgoglione, R., Scarcia, P., Pezzuto, F., Agrimi, G., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00315-1 · Cited by 138
VPS37A directs ESCRT recruitment for phagophore closure
Takahashi, Y., Liang, X., Hattori, T., Tang, Z., He, H., Chen, H., Liu, X., Abraham, T., Kawasawa, Y. I., Buchkovich, N. J., et al. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201902170 · Cited by 142
Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation
Boyle, K. A., Wickle, J. V., Hill, R. B., Marchese, A., Kalyanaraman, B., & Dwinell, M. B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001469 · Cited by 130
The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease
Romero, F. A., Jones, C. T., Xu, Y., Fenaux, M., & Halcomb, R. L. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01701 · Cited by 126
Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis
Finck, B. N. (2018) · Diabetes · doi:10.2337/dbi18-0024 · Cited by 125
Adipose Tissue Remodeling in Pathophysiology
Auger, C., & Kajimura, S. (2022) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-042220-023633 · Cited by 135
Astaxanthin as a Novel Mitochondrial Regulator: A New Aspect of Carotenoids, beyond Antioxidants
Nishida, Y., Nawaz, A., Hecht, K. A., & Tobe, K. (2021) · Nutrients · doi:10.3390/nu14010107 · Cited by 128
Pharmacological advances in mitochondrial therapy
Singh, A., Faccenda, D., & Campanella, M. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103244 · Cited by 128
Ligands for the Nuclear Peroxisome Proliferator-Activated Receptor Gamma
Sauer, S. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.06.010 · Cited by 122
The mitochondrial pyruvate carrier in health and disease: To carry or not to carry?
Bender, T., & Martinou, J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.017 · Cited by 122
PPARs modulate cardiac metabolism and mitochondrial function in diabetes
Lee, T., Bai, K., Lee, T.-I., Chao, T., Kao, Y., & Chen, Y. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-016-0309-5 · Cited by 116
Treating NASH by targeting peroxisome proliferator-activated receptors
Staels, B., Butruille, L., & Francque, S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.07.004 · Cited by 114
Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes
Hiyoshi, T., Fujiwara, M., & Zemin, Y. (2018) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160164 · Cited by 112
Brooks, G. A., & Martin, N. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00408 · Cited by 107
Ding, B., Parmigiani, A., Divakaruni, A. S., Archer, K. J., Murphy, A. N., & Budanov, A. V. (2016) · Scientific Reports · doi:10.1038/srep22538 · Cited by 112
Self-citationmitoNEET as a novel drug target for mitochondrial dysfunction
Geldenhuys, W. J., Leeper, T. C., & Carroll, R. T. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.05.001 · Cited by 108
Vigueira, P. A., McCommis, K. S., Schweitzer, G. G., Remedi, M. S., Chambers, K. T., Fu, X., McDonald, W. G., Cole, S. L., Colca, J. R., Kletzien, R. F., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.017 · Cited by 103
Self-citationArce‐Molina, R., Cortés‐Molina, F., Sandoval, P. Y., Galaz, A., Alegría, K., Schirmeier, S., Barros, L. F., & Martín, A. S. (2020) · eLife · doi:10.7554/elife.53917 · Cited by 102
Interferon-mediated reprogramming of membrane cholesterol to evade bacterial toxins
Zhou, Q., Chi, X., Lee, M. S., Hsieh, W. Y., Mkrtchyan, J. J., Feng, A., He, C. H., York, A. G., Bui, V. L., Kronenberger, E. B., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0695-4 · Cited by 101
The Pancreatic β-Cell: A Bioenergetic Perspective
Nicholls, D. G. (2016) · Physiological Reviews · doi:10.1152/physrev.00009.2016 · Cited by 100
Xu, L., Yan, X., Zhao, Y., Song, J., Liu, B., Yu, S., Fu, J., Liu, Y., & Su, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169252 · Cited by 109
Harrison, S. A., Thang, C., Bolze, S., Dewitt, S., Hallakou-Bozec, S., Dubourg, J., Bedossa, P., Cusi, K., Ratziu, V., Grouin, J.-M., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.004 · Cited by 96
Compan, V., Pierredon, S., Vanderperre, B., Krznar, P., Marchiq, I., Zamboni, N., Pouysségur, J., & Martinou, J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.035 · Cited by 92
Targeting Mitochondria in Diabetes
Jakovljevic, N. K., Pavlović, K., Jotić, A., Lalic, K. S., Stoiljkovic, M. M., Lukić, L., Milicic, T. J., Macesic, M. V., Gajović, J. S., & Lalic, N. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126642 · Cited by 91
Metabolic abnormalities and oxidative stress in lupus
Lightfoot, Y. L., Blanco, L. P., & Kaplan, M. J. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000413 · Cited by 85
Sarasamma, S., Audira, G., Juniardi, S., Sampurna, B. P., Liang, S., Hao, E., Lai, Y., & Hsiao, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103195 · Cited by 89
Du, J., Cleghorn, W. M., Contreras, L., Lindsay, K. J., Rountree, A. M., Chertov, A. O., Turner, S. J., Sahaboglu, A., Linton, J., Sadı́lek, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.507285 · Cited by 86
Mitochondrial pyruvate import and its effects on homeostasis
Vanderperre, B., Bender, T., Kunji, E. R. S., & Martinou, J. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.10.008 · Cited by 83
Multifaceted roles of mitochondria in wound healing and chronic wound pathogenesis
Hunt, M., Torres, M. S., Bachar-Wikström, E., & Wikström, J. D. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1252318 · Cited by 84
Rauckhorst, A. J., Gray, L. R., Sheldon, R. D., Fu, X., Pewa, A. D., Feddersen, C. R., Dupuy, A. J., Gibson-Corley, K. N., Cox, J. E., Burgess, S. C., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.09.002 · Cited by 74
Quansah, E., Peelaerts, W., Langston, J. W., Simon, D. K., Colca, J. R., & Brundin, P. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0260-x · Cited by 76
Self-citationPhua, W. W. T., Wong, M. X. Y., Liao, Z., & Tan, N. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051425 · Cited by 72
The yeast mitochondrial pyruvate carrier is a hetero-dimer in its functional state
Tavoulari, S., Thangaratnarajah, C., Mavridou, V., Harbour, M. E., Martinou, J., & Kunji, E. R. (2019) · The EMBO Journal · doi:10.15252/embj.2018100785 · Cited by 73
Mitochondrial involvement in skeletal muscle insulin resistance: A case of imbalanced bioenergetics
Affourtit, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.07.008 · Cited by 67
Shan, M., Zhang, S., Luo, Z., Deng, S., Ran, L., Zhou, Q., Wan, H., Ye, J., Qian, C., Fan, X., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.05.012 · Cited by 75
Regulation of pyruvate metabolism in metabolic-related diseases
Jeoung, N. H., Harris, C. R., & Harris, R. A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9284-2 · Cited by 68
Yaribeygi, H., Atkin, S. L., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27754 · Cited by 72
Zhao, Y., & Yang, Y. A. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.05.027 · Cited by 67
Vanderperre, B., Herzig, S., Krznar, P., Hörl, M., Ammar, Z., Montessuit, S., Pierredon, S., Zamboni, N., & Martinou, J. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006056 · Cited by 67
Shannon, C. E., Ragavan, M., Palavicini, J. P., Fourcaudot, M. J., Bakewell, T. M., Valdez, I., Ayala, I., Jin, E. S., Madesh, M., Han, X., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101154 · Cited by 64
Cofactor squelching: Artifact or fact?
Schmidt, S. F., Larsen, B. D., Loft, A., & Mandrup, S. (2016) · BioEssays · doi:10.1002/bies.201600034 · Cited by 56
Osman, I., & Segar, L. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.11.026 · Cited by 58
Yonutas, H. M., Hubbard, W. B., Pandya, J. D., Vekaria, H. J., Geldenhuys, W. J., & Sullivan, P. G. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113243 · Cited by 58
Reilly, S. M., Hung, C., Ahmadian, M., Zhao, P., Keinan, O., Gomez, A. V., DeLuca, J. H., Dadpey, B., Lu, D., Zaid, J., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0217-6 · Cited by 58
Self-citationShah, R. C., Matthews, D. C., Andrews, R. D., Capuano, A. W., Fleischman, D. A., VanderLugt, J. T., & Colca, J. R. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140616113406 · Cited by 58
Self-citationMitochondrial dysfunction has divergent, cell type-dependent effects on insulin action
Martin, S. D., Morrison, S., Konstantopoulos, N., & McGee, S. L. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.02.001 · Cited by 56
Changing appetites: the adaptive advantages of fuel choice
Stanley, I. A., Ribeiro, S. M., Giménez-Cassina, A., Norberg, E., & Danial, N. N. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.07.010 · Cited by 57
Metabolic perturbations in fibrosis disease
Ung, C. Y., Onoufriadis, A., Parsons, M., McGrath, J. A., & Shaw, T. J. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106073 · Cited by 55
Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
Huang, Y. Y., Gusdon, A. M., & Qu, S. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-171 · Cited by 55
LKB1 promotes metabolic flexibility in response to energy stress
Parker, S. J., Svensson, R. U., Divakaruni, A. S., Lefebvre, A. E. Y. T., Murphy, A. N., Shaw, R. J., & Metallo, C. M. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.12.010 · Cited by 54
Self-citationDiabetes as a risk factor for MASH progression
Gancheva, S., Roden, M., & Castéra, L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111846 · Cited by 60
Brust, R., Lin, H., Fuhrmann, J., Asteian, A., Kamenecka, T. M., & Kojetin, D. J. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b01015 · Cited by 55
Human mitochondrial pyruvate carrier 2 as an autonomous membrane transporter
Nagampalli, R. S. K., Quesñay, J. E. N., Adamóski, D., Islam, Z., Birch, J., Sebinelli, H. G., Girard, R. M. B. M., Ascenção, C. F. R., Fala, A. M., Pauletti, B. A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21740-z · Cited by 53
Blocking mitochondrial pyruvate import in brown adipocytes induces energy wasting via lipid cycling
Veliova, M., Ferreira, C. M., Benador, I. Y., Jones, A. E., Mahdaviani, K., Brownstein, A. J., Desousa, B. R., Acín‐Pérez, R., Petcherski, A., Assali, E. A., et al. (2020) · EMBO Reports · doi:10.15252/embr.201949634 · Cited by 55
Self-citationMASLD/MASH and type 2 diabetes: Two sides of the same coin? From single PPAR to pan-PPAR agonists
Cooreman, M. P., Vonghia, L., & Francque, S. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111688 · Cited by 55
Metadata
- Authors
- Divakaruni, A. S., Wiley, S. E., Rogers, G. W., Andreyev, A. Y., Petrosyan, S., Loviscach, M., Wall, E. A., Yadava, N., Heuck, A. P., Ferrick, D. A., Henry, R. R., McDonald, W. G., Colca, J. R., Simon, M. I., Ciaraldi, T. P., & Murphy, A. N.
- Affiliations
- Departments of aPharmacology and
- Seahorse Bioscience, North Billerica, MA 01862;
- VA San Diego Healthcare System (US)
- Pioneer Valley Life Sciences Institute, Springfield, MA 01107;
- University of Massachusetts Amherst (US)
- University of California San Diego (US)
- Metabolic Solutions Development Company (United States) (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-03-19
- Volume
- 110
- Issue
- 14
- Pages
- 5422-5427
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3619368
- OpenAlex
- W1981961082
- Cited by
- 308
- References
- 58
- Citations by year
- 2026: 15 · 2025: 22 · 2024: 25 · 2023: 22 · 2022: 25 · 2021: 26 · 2020: 27 · 2019: 20 · 2018: 27 · 2017: 24 · 2016: 23 · 2015: 16 · 2014: 24 · 2013: 12
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01HL085577)
- National Institute of Diabetes and Digestive and Kidney Diseases (R42DK081298, R24DK092154)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- thiazolidinediones, mitochondrial pyruvate carrier, MPC1, MPC2, pyruvate transport, mitochondrial respiration inhibition, methyl pyruvate, glucose uptake, skeletal muscle fibers, insulin sensitization, metabolic dysfunction
- MeSH terms
- Solute Carrier Proteins, Acrylates, Analysis of Variance, Animals, Cell Line, Glucose, Humans, Blotting, Western, Muscle, Skeletal, Cell Respiration, Reverse Transcriptase Polymerase Chain Reaction, Mitochondrial Proteins, Membrane Transport Proteins, Anion Transport Proteins, Monocarboxylic Acid Transporters, Mitochondrial Membrane Transport Proteins, Thiazolidinediones, Cytochromes c, Mitochondrial Membranes, Mice, Rats, Membrane Potential, Mitochondrial, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
